Table 1. Estimated number and proportion of MDR-TB cases among new and previously treated TB cases by selected country,* WHO Western Pacific Region.
Countries and areas | Data type | Year | MDR-TB among new cases | MDR-TB among previously treated TB cases | Total MDR-TB cases | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | (95% CI) | % | N | (95% CI) | % | N | (95% CI) | |||||
Australia | Surveillance | 2013 | 16 | (9–27) | 2 | (1–4) | 1 | (0–7) | 4 | (<1–21) | 17 | (8–26) |
Brunei Darussalam | Surveillance | 2013 | 1 | (0–6) | <1 | (<1–4) | 0 | (0–3) | 0 | (0–46) | 1 | (0–3) |
Cambodia | Survey | 2007 | 320 | (160–580) | 1 | (<1–3) | 180 | (68–370) | 11 | (4–22) | 510 | (270–740) |
China | Survey | 2007 | 45 000 | (35 000–55 000) | 6 | (5–7) | 9200 | (7800–11 000) | 26 | (22–30) | 54 000 | (48 000–61 000) |
Hong Kong Special Administrative Region | Surveillance | 2012 | 34 | (21–52) | <1 | (<1–1) | 9 | (3–20) | 3 | (<1–6) | 43 | (26–59) |
Macao Special Administrative Region | Surveillance | 2013 | 7 | (2–16) | 2 | (<1–5) | 4 | (1–10) | 12 | (2–30) | 11 | (4–18) |
Cook Islands | Surveillance | 2013 | 0 | (0–1) | 0 | (0–98) | 0 | (0–0) | 0 | (0–0) | 0 | (0–1) |
Japan | Surveillance | 2002 | 110 | (63–160) | <1 | (<1–1) | 100 | (72–130) | 10 | (7–13) | 200 | (150–260) |
Lao People’s Democratic Republic | Model† | 160 | (96–230) | 5 | (3–6) | 65 | (56–75) | 24 | (20–27) | 220 | (160–290) | |
Malaysia | Survey | 1997 | 19 | (0–120) | <1 | (0–<1) | 0 | (0–340) | 0 | (0–17) | 19 | (0–57) |
Marshall Islands | Surveillance | 2013 | 2 | (0–9) | 1 | (<1–7) | 0 | (0–5) | 0 | (0–71) | 2 | (0–5) |
New: Survey | 2007 | |||||||||||
Mongolia | Previously treated TB: Surveillance | 2013 | 33 | (16–59) | 1 | (<1–3) | 210 | (180–240) | 34 | (29–38) | 240 | (210–280) |
New Zealand | Surveillance | 2012 | 1 | (0–5) | <1 | (<1–3) | 2 | (0–5) | 17 | (2–48) | 3 | (0–6) |
Palau | Surveillance | 2013 | 0 | (0–3) | 0 | (0–41) | 0 | (0–0) | 0 | (0–0) | 0 | (0–3) |
Papua New Guinea | Model† | 560 | (340–800) | 5 | (3–6) | 570 | (480–650) | 24 | (20–27) | 1100 | (890–1400) | |
Philippines | Survey | 2013 | 4400 | (3100–6000) | 2 | (1–3) | 4100 | (3000–5500) | 21 | (16–29) | 8500 | (6900–10 000) |
Republic of Korea | Surveillance | 2004 | 780 | (600–980) | 3 | (2–3) | 1200 | (850–1600) | 14 | (10–19) | 1900 | (1600–2300) |
Singapore | Surveillance | 2013 | 17 | (8–30) | <1 | (<1–2) | 3 | (0–12) | 3 | (<1–9) | 20 | (9–31) |
Viet Nam | Survey | 2012 | 3000 | (1900–4100) | 4 | (3–5) | 2100 | (1500–2600) | 23 | (17–30) | 5100 | (4100–6100) |
Western Pacific Region | 53 000 | (31 000–75 000) | 4 | (3–6) | 18 000 | (15 000–21 000) | 22 | (18–26) | 71 000 | (47 000–94 000) |
Source: Global TB database.
CI, confidence interval; MDR-TB, multidrug-resistant tuberculosis.
* Countries that reported at least one MDR-TB case in 2013.
† Estimates of the proportion of new and previously treated TB cases that have MDR-TB were produced using modelling (including multiple imputation) that was based on data from countries that were considered to be similar in terms of TB epidemiology for which data do exist.